MDS Nordion

Press Room   |   Resource Library   |   Contact Us       

Home About Us Products & Services Partners News & Events Environmental Health & Safety Careers

 

Products & Services

 

Molecular Medicine Services

MDS Nordion is making a difference in the role that molecular imaging plays in the future of health care. Harnessing this innovative approach to medicine, and working with global partners, we are helping to improve the health and well-being of people around the world.

Isotope-based imaging provides pico-molar sensitivity, thereby enabling imaging at the molecular level. For example, the expression of a gene within a cell or the targeting of a select neurological receptor within a human can be imaged using targeted isotopes.

Advances in molecular and cell biology combined with powerful, non-invasive molecular imaging technologies provide researchers and physicians with valuable information, such as:

  • Faster and more effective identification of lead drug compounds;
  • More efficient development of new therapeutics to treat disease; and
  • Detection, diagnosis, and treatment at the earliest stages of disease.

MDS Nordion offers tailored solutions, leading expertise, and service capabilities for radiopharmaceutical development, clinical and commercial manufacturing, and radiation-based medical device development.

We are a proven partner offering:

  • An 80,000 square foot state-of-the-art good manufacturing practices (GMP) facility
  • Pilot scale through commercialization capabilities
  • Aseptic and terminal sterilization capabilities
  • Design and tested tailored packaging for customer needs
  • Reliable global distribution logistics
  • An excellent record of regulatory compliance with key international regulatory agencies including the United States Food & Drug Administration (USFDA), United States Nuclear Regulatory Commission (US NRC), United States Department of Transport (US DOT), Canadian Nuclear Safety Commission (CNSC), Health Canada and European Medicines Evaluation Agency (EMEA)

Building on this global footprint, we are expanding from our strength in radiopharmaceutical development, and creating a diverse portfolio of molecular imaging services: Discovery & Pre-clinical, Clinical and Commercialization, and Molecular Imaging Services.

Legal        Privacy        Sitemap